Stock-Based Compensation

$168.00M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$168.00Mperiod endingJun 30, 2026

EW Stock-Based Comp ($0.00 → $168.00M)

Annual stock-based compensation

High-resolution chart · PNG

EW stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	158,100,000
Dec 31, 2024	162,300,000
Dec 31, 2023	139,400,000
Dec 31, 2022	126,800,000
Dec 31, 2021	109,300,000
Dec 31, 2020	92,600,000
Dec 31, 2019	81,300,000
Dec 31, 2018	71,000,000
Dec 31, 2017	61,600,000
Dec 31, 2016	56,900,000
Dec 31, 2015	49,900,000
Dec 31, 2014	48,300,000
Dec 31, 2013	47,400,000
Dec 31, 2012	42,100,000
Dec 31, 2011	35,000,000
Dec 31, 2010	29,300,000
Dec 31, 2009	28,300,000
Dec 31, 2008	28,700,000
Dec 31, 2007	27,700,000
Dec 31, 2006	26,600,000
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0